Table 2.
Comparison of age-adjusted rates of contraceptive practices between the cancer survivor and general populations
| Contraceptive Status and Method | Cancer Survivors n=289 | General Population n=51,277* | P value |
|---|---|---|---|
| Percent (95% CI) | |||
| Using contraception | 57.4 (51.5 - 63.2) | 68.6 (67.3 - 70.0) | <0.01 |
| Contraception methods | <0.01 | ||
| WHO Tiers I/II† | 34.2 (28.8 - 40.0) | 53.0 (51.5 - 54.5) | |
| Female Sterilization† | 0.3 (0.0 - 1.9) | 19.9 (18.7 - 21.1) | |
| Male Sterilization | 4.2 (2.2 - 7.1) | 7.5 (6.7 - 8.4) | |
| Intrauterine Device | 5.9 (3.5 - 9.3) | 4.0 (3.5 - 4.6) | |
| Implant, Lunelle or Patch | 0.3 (0.0 - 1.9) | 0.9 (0.6 - 1.1) | |
| Pill | 20.8 (16.2 - 25.9) | 17.2 (16.1 - 18.4) | |
| 3-month Injectable (Depo-Provera) | 0.3 (0.0 - 1.9) | 2.0 (1.7 - 2.3) | |
| Contraceptive Ring | 2.4 (1.0 - 4.9) | 1.5 (1.1 - 1.8) | |
| WHO Tiers III/IV† | 23.2 (18.4 - 28.5) | 15.6 (14.5 - 16.6) | |
| Condom† | 20.4 (15.9 - 25.5) | 11.0 (10.1 - 11.9) | |
| Periodic Abstinence (family planning/calendar rhythm) | 1.7 (0.6 - 4.0) | 0.8 (0.6 - 1.1) | |
| Withdrawal† | 0.7 (0.1 - 2.5) | 3.4 (2.9 - 4.0) | |
| Other Methods | 0.0 (0.0 - 1.3) | 0.3 (0.1 - 0.5) | |
| Not using contraception | <0.01 | ||
| Surgically Sterile (female) † | 8.3 (5.4 - 12.1) | 0.4 (0.2 - 0.7) | |
| Nonsurgically Sterile‡(female or male) | -- | 1.9 (1.5 - 2.3) | |
| Pregnant or Postpartum† | 0.4 (0.0 - 1.9) | 4.7 (4.1 - 5.2) | |
| Seeking Pregnancy | 9.0 (6.0 - 12.9) | 5.4 (4.7 - 6.1) | |
| Not Sexually Active | 14.9 (11.0 - 19.5) | 11.0 (10.1 - 11.9) | |
| Sexually Active | 10.0 (6.8 - 14.1) | 7.9 (7.2 - 8.7) | |
Abbreviations: WHO, World Health Organization
*
General population as reported by the National Survey for Family Growth 2006-2010 cycle.15 Numbers are expressed in thousands and are based on applying sampling weights to 9995 respondents aged 20-44 years.
†
denotes non-overlapping 95% CIs of the proportions in the survivor and general populations.
‡
For survivors, nonsurgically sterile is unknown and not included in the above table.
Notes: Overall comparisons performed using SAS PROC SURVEYFREQ with age-group weights to standardize for age. P-values from chi-square tests of homogeneity.